ESR1 and cancer: Nonetheless, as discussed in Section 5, estrogen action on ER+ cancer cells, as well as endothelial, fibroblastic, and immune cell targets, can modulate expression of multiple cytokines and chemokines, which is predicted to alter the numbers and/or activities of immune cell subpopulations.